Clinical Trial Update: Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and immunogenicity of GSK's investigational malaria vaccine in HIV-infected infants and children completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• GSK Biologicals' investigational malaria vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria | Phase 3 | Status: COMPLETED | Results posted: 2019-01-16